NCT02117024: A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer |
|
|
| Terminated | 2 | 66 | US | Viagenpumatucel-L, HS-110, Metronomic Cyclophosphamide, Physician's Choice Regimen (Vinorelbine, Erlotinib, Gemcitabine, Paclitaxel, Docetaxel, Pemetrexed) | Heat Biologics | Non Small Cell Lung Cancer | 12/17 | 04/18 | | |
DURGA, NCT02439450: A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer |
|
|
| Completed | 1b/2 | 121 | US | Viagenpumatucel-L, HS-110, Nivolumab, Opdivo, Pembrolizumab, Keytruda, Pemetrexed, Alimta | Heat Biologics | Non-small Cell Lung Cancer | 05/21 | 11/22 | | |